PER 3.57% 8.1¢ percheron therapeutics limited

Ann: Trial Met Primary & Exceeded Secondary Endpoint Expectations, page-5

  1. 330 Posts.
    lightbulb Created with Sketch. 202
    A very positive result; let’s hope that this drug can at minimum provide the patients and thier families with a way to stabilise the disease a5 minimum. Really hope the6 allow compassionate use for those that wish to accept the risk of using an early stage drug that has not. completed phase 2b and phase 3 testing.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.1¢
Change
-0.003(3.57%)
Mkt cap ! $73.02M
Open High Low Value Volume
8.2¢ 8.2¢ 8.1¢ $17.84K 219.1K

Buyers (Bids)

No. Vol. Price($)
5 141084 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.3¢ 59816 1
View Market Depth
Last trade - 13.13pm 26/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.